Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus.

Documenti analoghi

• B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.
  di: Spronk, P E, et al.
  Pubblicazione: (1993)
• Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE)
  di: SPRONK, P E, et al.
  Pubblicazione: (1996)
• Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.
  di: Swaak, A J, et al.
  Pubblicazione: (1986)
• Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus
  di: Giles, Brendan M., et al.
  Pubblicazione: (2013)
• Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement
  di: Bijl, M, et al.
  Pubblicazione: (2006)